Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition and application thereof

A composition and drug technology, applied in drug combination, drug delivery, medical formula, etc., can solve problems such as uncertain sedative effect, easy to be awakened by external stimuli, pain stimulation, etc., to achieve strong controllability of waking up and drug onset Fast, less side effects

Inactive Publication Date: 2017-05-31
CHONGQING YUBEIHAI TECH CO LTD
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The efficacy and use of these sedatives have the following problems: (1) chloral hydrate oral agent: it is the most commonly used sedative agent for children before examination in outpatient clinics. Because its mouthfeel is very bitter, many children refuse to take it or cause vomiting after taking it. Increased risk of aspiration, even life-threatening
In addition, the metabolites of chloral hydrate are active and sometimes cause delayed awakening; at the same time, the first-pass effect of the drug is obvious, and the sedative effect is uncertain, which often leads to sedation failure, and many children often need repeated medications
(2) Oral midazolam: the sedative effect is not good, and the success rate is only 60-75%
(3) Lumin sodium intramuscular injection: the success rate of sedation is about 80%, but it is accompanied by painful stimulation, which will cause harm to children
[0004] Dexmedetomidine hydrochloride is the dextro isomer of medetomidine, which is a derivative of imidazoles and is a highly selective α2 receptor agonist. The chemical name is: (+)-4-(S) -[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride acts on the α2 receptor in the locus coeruleus nucleus of the brainstem to produce a good sedative effect. The bioavailability of medetomidine is 81.8% (72.6-92.1%), so adults and children can produce obvious sedative effect after nasal instillation of dexmedetomidine, and it has no inhibitory effect on the respiratory center; but 2ug alone After sedation with dexmedetomidine / kg, it is easy to be awakened by external stimuli, and the awakening rate can reach about 50%, resulting in failure of sedation; large doses of dexmedetomidine hydrochloride (>2ug / kg) intranasally can produce heartbeat Brady phenomenon
[0005] Ketamine is an NMDA receptor antagonist, which has analgesic, sedative and sympathetic stimulation effects, but generally its use requires a large dose, which can easily cause blood pressure to rise and there is agitation during the recovery period

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition and application thereof
  • Medicine composition and application thereof
  • Medicine composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A kind of sedative medicine, containing dexmedetomidine hydrochloride and ketamine hydrochloride and pharmaceutically acceptable auxiliary materials, it is prepared into nasal spray, and it is prepared according to the following steps:

[0029] Prescription composition:

[0030]

[0031] 1. Take 2L of purified water and put it in the liquid mixing tank, set the mixing speed to 60-80 rpm, slowly add the prescribed amount of polyethylene glycol 400, stir while adding, after adding the polyethylene glycol 400, continue stir, spare;

[0032] 2. After continuing to stir for 20 minutes, add dexmedetomidine hydrochloride, ketamine hydrochloride, glycerin, sodium chloride, disodium edetate, benzyl alcohol in sequence, add purified water until the volume of the liquid is 8L, and continue stirring to dissolve ,spare;

[0033] 3. While stirring, add sodium bicarbonate to adjust the pH of the solution to 5.0-7.0, make up the remaining purified water, filter it with a 0.22 micr...

Embodiment 2

[0036] A kind of sedative medicine, containing dexmedetomidine hydrochloride and ketamine hydrochloride and pharmaceutically acceptable adjuvants, it is prepared into injection, according to the following steps:

[0037] Element Dosage (parts by weight) Dexmedetomidine Hydrochloride 0.005 copies Ketamine hydrochloride 0.5 parts Mannitol 3.7 servings Sodium chloride 1.1 copies Sterile water for injection Add to 2000ml

[0038] Preparation process:

[0039] 1. Concentrated formulation: Add the above-mentioned raw and auxiliary materials into the batching tank, then add 1 / 3 of the prescription amount of sterile water for injection, stir, dissolve, and obtain a concentrated formulation;

[0040] 2. Dilute preparation: take the concentrated preparation, add 0.1mol / L sodium bicarbonate solution, adjust the pH to 6.5-7.0, stir, mix well, filter with a 0.8μm filter membrane, and add 0.1%-0.3% mass of the total volume Activated carbon...

Embodiment 3

[0045] A kind of sedative medicine, containing dexmedetomidine hydrochloride and ketamine hydrochloride and pharmaceutically acceptable adjuvant, it is prepared into tablet, according to the following steps:

[0046]

[0047] Preparation process:

[0048] 1. Dexmedetomidine hydrochloride, ketamine hydrochloride, magnesium stearate, magnesium lauryl sulfate, sodium carboxymethyl starch and starch were pulverized respectively, passed through a 80-mesh sieve, and set aside;

[0049] 2. Mix dexmedetomidine hydrochloride, ketamine hydrochloride, magnesium lauryl sulfate, sodium carboxymethyl starch and starch evenly, and add 20% ethanol solution to make a soft material;

[0050] 3. Take the soft material obtained above, granulate it with a 18-mesh sieve, place the granules in a hot air oven, set the temperature at 60°C, dry until the moisture content of the granules is ≤3%, and granulate with an 18-mesh sieve;

[0051] 4. Take the above granules, add lubricant, and mix well;

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Medicine composition is characterized by comprising an effective medicine component comprising dexmedetomidine hydrochloride and ketamine hydrochloride. The medicine composition has a synergistic effect, is particularly used for sedation before examination of a child and has a significant effect, and various examinations can be performed on the sick child safely and effectively. The successful sedation rate can reach 96% or higher, the medicine takes effect quickly, and the analepsia controllability is high. Meanwhile, the medicine composition has little side effect and has no obvious adverse reactions, the child taking the medicine composition is normal in heart rate, blood pressure and the like and has no emergence agitation phenomena and the like, and the medicine has high safety.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a sedative pharmaceutical composition. Background technique [0002] Pre-examination sedation, especially for children, is a clinical problem that needs to be solved urgently. The use of safe and effective drugs is the key to ensure that children can successfully complete various examinations. [0003] At present, the commonly used sedative drugs before examination in China are oral chloral hydrate or midazolam, and intramuscular injection of sodium lumina. The efficacy and use of these sedatives have the following problems: (1) chloral hydrate oral agent: it is the most commonly used sedative agent for children before examination in outpatient clinics. Because its mouthfeel is very bitter, many children refuse to take it or cause vomiting after taking it. Increased risk of aspiration, even life threatening. In addition, the metabolites of chloral hydrate are active and sometimes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4174A61K31/137A61K9/12A61P25/20
CPCA61K9/0043A61K31/137A61K31/4174A61K47/183A61K2300/00
Inventor 叶茂徐颖
Owner CHONGQING YUBEIHAI TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products